Literature DB >> 10423517

Sulfating-activity and stability of cDNA-expressed allozymes of human phenol sulfotransferase, ST1A3*1 ((213)Arg) and ST1A3*2 ((213)His), both of which exist in Japanese as well as Caucasians.

S Ozawa1, M Shimizu, T Katoh, A Miyajima, Y Ohno, Y Matsumoto, M Fukuoka, Y M Tang, N P Lang, F F Kadlubar.   

Abstract

We recently found single amino acid substitutions ((213)Arg/His and (223)Met/Val) in polymorphic human phenol-sulfating phenol sulfotransferase (SULT: cDNAs encoding ST1A3, P PST or HAST1/2) among Caucasians and African-Americans. In a Japanese population (n = 143), allele frequencies of (213)Arg and (213)His were 83.2 and 16. 8%, respectively, but the (223)Val allele was not found. (213)His homozygosity was reportedly associated with both very low (>7-fold) sulfating activities of p-nitrophenol (at 4 microM) and low thermostability in platelets. Sulfating-activity determinations using recombinant (213)Arg- and (213)His-forms (ST1A3*1 and ST1A3*2, respectively) did not, however, reveal appreciable deficiency in [(35)S]3'-phosphoadenosine 5'-phosphosulfate (PAPS)-dependent sulfation of p-nitrophenol (4 microM) by ST1A3*2 (7.5 vs. 10.2 nmol/min/nmol SULT for ST1A3). Kinetic parameters for p-nitrophenol for p-nitrophenol sulfation supported the slight decrease in sulfating activities at 4 microM (K(m), 0.82 vs. 1.75 microM; V(max), 13.2 vs. 13.1 nmol/min/nmol SULT, respectively, for ST1A3*1 and *2). p-Nitrophenyl sulfate-dependent 2-naphthol sulfation by ST1A3*2 was 69% of that by ST1A3*1 (p<0.05). However, ST1A3*2 was remarkably unstable at 45 and 37 degrees C as compared to ST1A3*1. The lower p-nitrophenol sulfating activity of ST1A3*2 may explain the lower platelet p-nitrophenol sulfation in ST1A3*2 homozygotes. Protein instability and ST1A3 gene regulation may be both involved in the polymorphism of p-nitrophenol sulfation in human tissues.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10423517     DOI: 10.1093/oxfordjournals.jbchem.a022445

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  11 in total

1.  Association of genotypes of carcinogen-metabolizing enzymes and smoking status with bladder cancer in a Japanese population.

Authors:  Xiaoyi Cui; Xi Lu; Mizue Hiura; Hisamitsu Omori; Wataru Miyazaki; Takahiko Katoh
Journal:  Environ Health Prev Med       Date:  2012-09-09       Impact factor: 3.674

2.  Association between the SULT1A1 Arg213His polymorphism and the risk of bladder cancer: a meta-analysis.

Authors:  Chih-Ming Su; Mei-Chieh Chen; I-Chan Lin; Hsin-An Chen; Ming-Te Huang; Chih-Hsiung Wu; Kun-Hung Shen; Yuan-Hung Wang
Journal:  Tumour Biol       Date:  2014-04-25

Review 3.  Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines.

Authors:  Robert J Turesky; Loic Le Marchand
Journal:  Chem Res Toxicol       Date:  2011-06-20       Impact factor: 3.739

4.  Effects of the human SULT1A1 polymorphisms on the sulfation of acetaminophen,O-desmethylnaproxen, and tapentadol.

Authors:  Mohammed I Rasool; Ahsan F Bairam; Saud A Gohal; Amal A El Daibani; Fatemah A Alherz; Maryam S Abunnaja; Eid S Alatwi; Katsuhisa Kurogi; Ming-Cheh Liu
Journal:  Pharmacol Rep       Date:  2018-12-10       Impact factor: 3.024

5.  Functional genetic variants in the 3'-untranslated region of sulfotransferase isoform 1A1 (SULT1A1) and their effect on enzymatic activity.

Authors:  Xinfeng Yu; Ishwori B Dhakal; Marjorie Beggs; Vineetha Koroth Edavana; Suzanne Williams; Xuemei Zhang; Kelly Mercer; Baitang Ning; Nicholas P Lang; Fred F Kadlubar; Susan Kadlubar
Journal:  Toxicol Sci       Date:  2010-09-29       Impact factor: 4.849

Review 6.  Pharmacogenetics of soluble sulfotransferases (SULTs).

Authors:  Hansruedi Glatt; Walter Meinl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-05       Impact factor: 3.000

7.  Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer.

Authors:  Hiromasa Tsukino; Yoshiki Kuroda; Hiroyuki Nakao; Hirohisa Imai; Hisato Inatomi; Yukio Osada; Takahiko Katoh
Journal:  J Cancer Res Clin Oncol       Date:  2003-11-27       Impact factor: 4.553

8.  Lack of association of SULT1A1 R213H polymorphism with colorectal cancer: a meta-analysis.

Authors:  Chun Zhang; Jian-Ping Li; Guo-Qiang Lv; Xian-Min Yu; Yuan-Long Gu; Ping Zhou
Journal:  PLoS One       Date:  2011-06-13       Impact factor: 3.240

Review 9.  SULT genetic polymorphisms: physiological, pharmacological and clinical implications.

Authors:  Katsuhisa Kurogi; Mohammed I Rasool; Fatemah A Alherz; Amal A El Daibani; Ahsan F Bairam; Maryam S Abunnaja; Shin Yasuda; Lauren J Wilson; Ying Hui; Ming-Cheh Liu
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-06-30       Impact factor: 4.936

10.  Copy number variation in sulfotransferase isoform 1A1 (SULT1A1) is significantly associated with enzymatic activity in Japanese subjects.

Authors:  Xinfeng Yu; Takahiro Kubota; Ishwori Dhakal; Setsuo Hasegawa; Suzanne Williams; Shogo Ozawa; Susan Kadlubar
Journal:  Pharmgenomics Pers Med       Date:  2013-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.